Breast Cancer Clinical Trials in Nashville

Showing 461-480 of 605 trials

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors

NCT02403271

This is a Phase 1b/2, multi-center study to assess the safety and efficacy of ibrutinib in combination with durvalumab (MEDI4736) in participants with relapsed or refractory solid tumors.

Non-Small Cell Lung CancerBreast CancerPancreatic Cancer

Pharmacyclics LLC.124 participantsStarted Mar 2015

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • La Jolla, California, United States +14 more locations

COMPLETEDPhase 2< 1 mile

Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer

NCT01277757

This phase II trial studies how well Akt inhibitor MK2206 works in treating patients with breast cancer cancer that has spread to other places in the body and usually cannot be cured or controlled with treatment. Akt inhibitor MK2206 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Recurrent Breast CarcinomaStage IIIB Breast CancerStage IIIC Breast Cancer+1 more

National Cancer Institute (NCI)30 participantsStarted Mar 2011

Boston, Massachusetts, United States • Boston, Massachusetts, United States • New York, New York, United States +2 more locations

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors

Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer

Breast Cancer Trials in Other Cities

A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer

A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

Cryoablation of Small Breast Tumors in Early Stage Breast Cancer

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

A Study of LY573636-sodium in Patients With Metastatic Breast Cancer

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer

hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

A Study Evaluating MM-310 in Patients With Solid Tumors

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer

A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)

Other Conditions in Nashville